Oncologists’ Perspectives on Multi-Cancer Early Detection

Oncologists Tyler Kang, MD and Daniel Mackey, MD share the impact MCED has had on their patients and practices.

Up Next

Stories of Early Cancer Detection

By playing the video above you consent to accept Vimeo cookies.

Stories of Early Cancer Detection

Hear the experiences of several individuals whose lives were impacted by multi-cancer early detection screening.

Up Next

The Importance of Detecting Cancer Early

By playing the video above you consent to accept Vimeo cookies.

The Importance of Detecting Cancer Early

Cindy’s cancer support system gave her the care and resources needed to tackle early stage cancer.

Up Next

How Rich Found his Cancer Early

By playing the video above you consent to accept Vimeo cookies.

How Rich Found his Cancer Early

Rich took a multi-cancer early detection test, offered by his Nationwide life insurance policy. To his surprise, the results led to a cancer diagnosis.

Up Next

An Unexpected Result

By playing the video above you consent to accept Vimeo cookies.

An Unexpected Result

Jennifer’s proactive approach to multi-cancer early detection testing with her husband, Jonathan, led to an unexpected discovery when he received a “cancer signal detected” result.

Up Next

Oncologists’ Perspectives on Multi-Cancer Early Detection

By playing the video above you consent to accept Vimeo cookies.

Our Mission

Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe and effective technologies that can transform cancer screening.

Join Our Team
A Grail lab technician working
The Galleri® Test

The Galleri test is a first-of-its-kind multi-cancer early detection (MCED) test that can help screen for many of the deadliest cancers that don’t have recommended screening today. 

Galleri does not detect all cancers and all cancers cannot be detected in the blood.

Learn More
Multi-Cancer Early Detection

Multi-cancer early detection (MCED) blood tests analyze DNA that has been shed into the bloodstream by all cells growing in the body, including cancer cells. 

Learn More
Methylation

GRAIL’s Methylation Platform preferentially targets the most informative regions of the genome and uses machine-learning algorithms to detect methylation patterns associated with cancer and, when found, predict the cancer signal origin.

Learn More

Who We Are

GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, when it may be more treatable and potentially curable.

Learn About Us
Grail lab technicians working

On this monthly podcast, host Susanna Quinn explores topics relating to early cancer detection testing, including multi-cancer early detection testing, cancer genomics and risk, barriers to cancer screening, and much more.